REGENERON PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 883.2 USD | -0.84% |
|
-1.52% | +0.56% |
| 04-26 | Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says | MT |
| 04-26 | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 23/04/2024 | 24/04/2024 | 25/04/2024 | 26/04/2024 | |
|---|---|---|---|---|
| Last | 907.32 $ | 906.54 $ | 890.68 $ | 883.2 $ |
| Volume | 341 220 | 373 718 | 576 565 | 505 652 |
| Change | +0.80% | -0.09% | -1.75% | -0.84% |
| Opening | 905.66 | 906.90 | 911.09 | 881.72 |
| High | 912.74 | 915.70 | 915.00 | 887.48 |
| Low | 903.83 | 904.41 | 876.75 | 875.23 |
Performance
| 1 day | -0.84% | ||
| 1 week | -1.52% | ||
| Current month | -8.24% | ||
| 1 month | -8.34% | ||
| 3 months | -6.05% | ||
| 6 months | +11.51% | ||
| Current year | +0.56% | ||
| 1 year | +13.52% | ||
| 3 years | +76.23% | ||
| 5 years | +157.00% | ||
| 10 years | +210.53% |
Volumes
marketsDaily volume
505 652
Estimated daily volume
505 652
Avg. Volume 20 sessions
467 627
Daily volume ratio
1.08
Avg. Volume 20 sessions USD
413 008 166.40
Record volume 1
28 282 394
Record volume 2
15 385 360
Record volume 3
13 646 090
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
95 284 476 249
Net sales (USD)
13 117 200 000
Number of employees
13 450
Sales / Employee (USD)
975 257
Free-Float
77.81 %
Free-Float capitalization (USD)
93 248 361 100
Average Daily Capital Traded
0.43%
Highs and lows
1 week
875.23
915.70
1 month
875.23970.79
Current year
871.39998.33
1 year
684.81998.33
3 years
478.40998.33
5 years
271.37998.33
10 years
269.50998.33
Indicators
Moving average 5 days
897.58
Moving average 20 days
922.51
Moving average 50 days
949.16
Moving average 100 days
925.82
Price spread / (MMA5)
+1.63%
Price spread / (MMA20)
+4.45%
Price spread / (MMA50)
+7.47%
Price spread / (MMA100)
+4.83%
STIM
RSI 9 days
28.91
RSI 14 days
31.27
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.84% | -1.52% | +0.56% | +13.52% | 95.28B | ||
| -0.06% | +0.81% | -2.31% | +22.94% | 103B | ||
| +0.90% | +3.56% | +1.69% | +0.60% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -21.15% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.49% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -37.19% | 16.74B | ||
| +3.38% | +18.58% | -14.85% | -37.58% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +32.39% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +5.31% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -33.33% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +280.10% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +77.79% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +51.30% | 7.71B | ||
| +5.81% | +6.81% | -54.46% | -71.20% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +28.46% | 6.99B | ||
| +0.83% | -3.27% | -21.74% | +75.93% | 6.85B | ||
| Average | +1.18% | +3.58% | +9.96% | +22.40% | ||
| Weighted average by Cap. | +0.43% | +1.78% | +1.65% | +13.99% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
06bf970c155ec3fb58ae7e2133f11.nJ-LUxef0-GBOG_NlOLsuxhfhNLukiiXI81KjKPD9j8.8cXNBV3AnrPqSjmBw9WPyWEvyKCb9B-ue5oCw8qTmQfr2tIcTvjqtqx_DA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 21:00:00 | 883.2 | 66,766 | 238,380 |
| 20:59:59 | 883.2 | 187 | 171,614 |
| 20:59:59 | 882.1 | 159 | 171,427 |
| 20:59:59 | 882.1 | 141 | 171,268 |
| 20:59:59 | 882.4 | 100 | 171,127 |
| 20:59:59 | 882.4 | 100 | 171,027 |
| 20:59:59 | 882.6 | 100 | 170,927 |
| 20:59:59 | 882.6 | 100 | 170,827 |
| 20:59:59 | 882.6 | 100 | 170,727 |
| 20:59:59 | 882.6 | 100 | 170,627 |
Monthly variations
Annual change
| 2024 | +0.56% | ||
| 2023 | +21.73% | ||
| 2022 | +14.25% | ||
| 2021 | +30.72% | ||
| 2020 | +28.66% | ||
| 2019 | +0.53% | ||
| 2018 | -0.65% | ||
| 2017 | +2.42% | ||
| 2016 | -32.38% | ||
| 2015 | +32.33% | ||
| 2014 | +49.05% | ||
| 2013 | +60.89% | ||
| 2012 | +208.62% | ||
| 2011 | +68.84% | ||
| 2010 | +35.77% | ||
| 2009 | +31.70% | ||
| 2008 | -23.98% | ||
| 2007 | +20.33% | ||
| 2006 | +26.23% | ||
| 2005 | +72.64% | ||
| 2004 | -37.39% | ||
| 2003 | -20.53% | ||
| 2002 | -34.27% | ||
| 2001 | -20.15% | ||
| 2000 | +176.59% | ||
| 1999 | +72.88% | ||
| 1998 | -13.87% | ||
| 1997 | -46.90% | ||
| 1996 | +26.47% | ||
| 1995 | +325.00% | ||
| 1994 | -80.65% | ||
| 1993 | +29.17% | ||
| 1992 | -33.79% | ||
| 1991 | -14.20% |
- Stock Market
- Equities
- REGN Stock
- Quotes Regeneron Pharmaceuticals, Inc.
